David E. Potter
Impact in
- Geriatrics and Gerontology top 0.5%
- Pharmaceutical Practices and Patient Outcomes
- Ophthalmology top 0.5%
- Glaucoma and retinal disorders
Papers in
-
- Receptor Mechanisms and Signaling 30
- Physiology 42
- Nitric Oxide and Endothelin Effects 18
- Pain Mechanisms and Treatments 13
- Adipose Tissue and Metabolism 8
- Co-authors
- James A. Burke (16 shared papers)J. Mark Rowland (12 shared papers)Alan Lyles (2 shared papers)Judith D. Kasper (2 shared papers)Denys T. Lau (2 shared papers)Richard G. Bennett (1 shared paper)Teh‐Ching Chu (15 shared papers)R. J. Reiter (1 shared paper)
- Journals
- Journal of Ocular Pharmacology and Therapeutics (19 papers)Current Eye Research (17 papers)Pharmacology (12 papers)Experimental Eye Research (10 papers)Journal of Pharmacology and Experimental Therapeutics (9 papers)
- Partner nations
- United StatesUnited KingdomIreland
In The Last Decade
David E. Potter
131 papers receiving 3.1k citations
Peers
Comparison fields: 5 of 157
- Geriatrics and Gerontology 351
- Ophthalmology 713
- Cellular and Molecular Neuroscience 463
- Family Practice 41
- Physiology 402
Countries citing papers authored by David E. Potter
This map shows the geographic impact of David E. Potter's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by David E. Potter with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites David E. Potter more than expected).
Fields of papers citing papers by David E. Potter
This network shows the impact of papers produced by David E. Potter. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by David E. Potter. The network helps show where David E. Potter may publish in the future.
Co-authors
The 25 scholars most cited alongside David E. Potter, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 137 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | 2005 | 363 | |
| 2 | The Medical Expenditure Panel Survey: a national health information resource. | 1997 | 305 |
| 3 | 1971 | 139 | |
| 4 | 1981 | 138 | |
| 5 | 2004 | 121 | |
| 6 | 1978 | 112 | |
| 7 | 1986 | 88 | |
| 8 | 1978 | 83 | |
| 9 | 1965 | 64 | |
| 10 | 1978 | 63 | |
| 11 | 1981 | 61 | |
| 12 | 2009 | 57 | |
| 13 | 1990 | 54 | |
| 14 | 2007 | 50 | |
| 15 | 1982 | 44 | |
| 16 | 2005 | 42 | |
| 17 | 2012 | 40 | |
| 18 | 2014 | 40 | |
| 19 | 1984 | 37 | |
| 20 | 1986 | 36 |
About David E. Potter
David E. Potter is a scholar working on Molecular Biology, Physiology, Ophthalmology, Cellular and Molecular Neuroscience and Animal Science and Zoology, having authored 137 papers that have together received 3.3k indexed citations. Recurring topics across this work include Glaucoma and retinal disorders (41 papers), Receptor Mechanisms and Signaling (30 papers), Neuropeptides and Animal Physiology (21 papers), Nitric Oxide and Endothelin Effects (18 papers), Pain Mechanisms and Treatments (13 papers), Pharmacological Effects and Assays (11 papers), Eicosanoids and Hypertension Pharmacology (10 papers) and Adipose Tissue and Metabolism (8 papers). The work is most often cited by research in Geriatrics and Gerontology (351 citations), Ophthalmology (713 citations), Cellular and Molecular Neuroscience (463 citations), Family Practice (41 citations) and Physiology (402 citations). David E. Potter has collaborated with scholars based in United States, United Kingdom and Ireland. Frequent co-authors include James A. Burke, J. Mark Rowland, Alan Lyles, Judith D. Kasper, Denys T. Lau, Richard G. Bennett, Teh‐Ching Chu, R. J. Reiter, Craig E. Crosson and Steven B. Cohen. Their work appears in journals such as Journal of Ocular Pharmacology and Therapeutics, Current Eye Research, Pharmacology, Experimental Eye Research and Journal of Pharmacology and Experimental Therapeutics.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.